In 2001, the World Health Organization (WHO) began a 2- phase project called the WHO Research Into Global Hazards of Travel (WRIGHT) Project. The objectives of the project were to confirm that the risk of venous thromboembolism (VTE) is increased by air travel and to determine the magnitude of risk, the effect of other factors on the risk, and the effect of preventive measures on risk.
The key findings of the WRIGHT Phase I report include the following:
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs